Jose Rivas Rios, MD, FACC
Assistant Professor, University of Florida
On This Page
About Jose Rivas Rios
Jose Rivas Rios, MD, FACC, is an Assistant Professor of Medicine at the University of Florida College of Medicine–Jacksonville and a cardiologist with UF Health Jacksonville. He specializes in general and preventive cardiology, cardiometabolic medicine, and advanced cardiovascular imaging. Dr. Rivas Rios earned his medical degree, graduating Magna cum laude, from the University of Zulia in Maracaibo, Venezuela. He subsequently completed both his Internal Medicine residency and cardiovascular disease fellowship at the University of Florida College of Medicine–Jacksonville. Board certified in Internal Medicine and Cardiovascular Disease, Dr. Rivas Rios is committed to delivering patient-centered, evidence-based cardiovascular care with a strong emphasis on prevention, early detection, risk-factor modification, and comprehensive cardiovascular health. His clinical and academic interests include preventive cardiology, cardiometabolic disorders, cardiovascular imaging, and strategies to reduce the burden of atherosclerotic cardiovascular disease.
-
Assistant Professor
2023 – Current · University of Florida
Board Certifications
-
Cardiovascular DiseaseAmerican Board of Internal Medicine
-
Internal MedicineAmerican Board of Internal Medicine
Clinical Profile
Specialties
- General Internal Medicine
Subspecialties
- Cardiology
- Cardiovascular Disease
Publications
Academic Articles
Grants
-
A Placebo-Controlled, Double-Blind, Randomized, Phase 3 Study to Evaluate the Effect of Obicetrapib 10 mg and Ezetimibe 10 mg Fixed-Dose Combination or Obicetrapib 10 mg Daily on Top of Guideline-Recommended Lipid-Lowering Therapy in Participants With Type 2 Diabetes and/or Metabolic Syndrome
Active
- Role:
- Principal Investigator
- Funding:
- FORTREA via NEWAMSTERDAM PHARMA
-
A Phase III, Randomised, Double-blind Study to Evaluate the Effect of Balcinrenone/Dapagliflozin, Compared with Dapagliflozin, on the Risk of Heart Failure Events and Cardiovascular Death in Patients with Heart Failure and Impaired Kidney Function
Active
- Role:
- Principal Investigator
- Funding:
- ASTRAZENECA PHARM
-
Protocol Title: A Phase 3 Randomized, Placebo-Controlled Clinical Study to Evaluate the Efficacy and Safety of MK-0616 in Reducing Major Adverse Cardiovascular Events in Participants at High Cardiovascular Risk
Active
- Role:
- Principal Investigator
- Funding:
- MERCK AND COMPANY INC
Education
-
Cardiovascular Disease Fellowship
University of Florida College of Medicine – Jacksonville
-
Internal Medicine Residency
University of Florida College of Medicine – Jacksonville
-
Doctor of Medicine
University of Zulia School of Medicine
Contact Details
- Business:
- (904) 244-3907
- Business:
- jose.rivas@jax.ufl.edu
- Business Mailing:
-
UFCOM-J DEPT OF MEDICINE DIVISION OF CARDIOLOGY
653 W 8TH ST # L18
JACKSONVILLE FL 32209-6511